Botulinum toxin screening assays

Details for Australian Patent Application No. 2005216547 (hide)

Owner Allergan, Inc.

Inventors Gary, Patton E.; Fernandez-Salas, Ester; Aoki, Kei Roger

Agent Davies Collison Cave

Pub. Number AU-B-2005216547

PCT Pub. Number WO2005/082096

Priority 60/547,591 24.02.04 US

Filing date 23 February 2005

Wipo publication date 9 September 2005

Acceptance publication date 12 March 2009

International Classifications

C12Q 1/00 (2006.01) Measuring or testing processes involving enzymes or micro-organisms

Event Publications

14 September 2006 PCT application entered the National Phase

  PCT publication WO2005/082096 Priority application(s): WO2005/082096

12 March 2009 Application Accepted

  Published as AU-B-2005216547

9 July 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005216549-Polony fluorescent in situ sequencing beads

2005216540-Immunosuppressant compounds and compositions